IN2015DN01767A - - Google Patents
Info
- Publication number
- IN2015DN01767A IN2015DN01767A IN1767DEN2015A IN2015DN01767A IN 2015DN01767 A IN2015DN01767 A IN 2015DN01767A IN 1767DEN2015 A IN1767DEN2015 A IN 1767DEN2015A IN 2015DN01767 A IN2015DN01767 A IN 2015DN01767A
- Authority
- IN
- India
- Prior art keywords
- probnp
- mortality
- transplantation
- subjects
- prediction
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
Landscapes
- Medical Informatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Health & Medical Sciences (AREA)
- Pathology (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261691706P | 2012-08-21 | 2012-08-21 | |
PCT/US2013/056020 WO2014031764A1 (en) | 2012-08-21 | 2013-08-21 | Multimarker risk stratification |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2015DN01767A true IN2015DN01767A (sl) | 2015-05-29 |
Family
ID=50148799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1767DEN2015 IN2015DN01767A (sl) | 2012-08-21 | 2013-08-21 |
Country Status (12)
Country | Link |
---|---|
US (4) | US20140058743A1 (sl) |
EP (1) | EP2888687B1 (sl) |
JP (3) | JP6450679B2 (sl) |
CN (2) | CN104737170A (sl) |
AU (3) | AU2013305829A1 (sl) |
CA (1) | CA2882303A1 (sl) |
HK (2) | HK1208092A1 (sl) |
IN (1) | IN2015DN01767A (sl) |
MX (2) | MX2015002254A (sl) |
RU (1) | RU2015110054A (sl) |
SG (2) | SG11201501271TA (sl) |
WO (1) | WO2014031764A1 (sl) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002038794A2 (en) | 2000-11-09 | 2002-05-16 | The Brigham And Women's Hospital, Inc. | Cardiovascular disease diagnostic and therapeutic targets |
PT3072978T (pt) | 2002-05-09 | 2018-10-15 | Brigham & Womens Hospital Inc | 1l1rl-1 como um marcador de doença cardiovascular |
ES2646142T3 (es) | 2006-04-24 | 2017-12-12 | Critical Care Diagnostics, Inc. | Evaluación de la eficacia de un tratamiento en un sujeto en función de los niveles de ST2 |
DK2021796T3 (da) | 2006-05-01 | 2012-05-29 | Critical Care Diagnostics Inc | Diagnose af hjerte-kar-sygdom |
SI2827152T1 (sl) | 2008-04-18 | 2016-10-28 | Critical Care Diagnostics,Inc. | Napovedovanje tveganja večjih neželenih srčno-žilnih dogodkov |
RU2625014C2 (ru) | 2010-04-09 | 2017-07-11 | Критикал Кэа Дайэгностикс, Инк. | Антитела против растворимого st-2 человека и способы анализа |
US8728742B2 (en) | 2011-03-17 | 2014-05-20 | Critical Care Diagnostics, Inc. | Methods predicting risk of an adverse clinical outcome |
JP6134316B2 (ja) | 2011-07-18 | 2017-05-24 | クリティカル ケア ダイアグノスティクス インコーポレイテッド | 心臓血管疾患を治療する方法および運動療法の有効性を予測する方法 |
EP3434260A1 (en) | 2012-05-18 | 2019-01-30 | Critical Care Diagnostics, Inc. | Methods for treating or predicting risk of ventricular tachyarrhythmia event |
RU2019107598A (ru) | 2012-08-16 | 2019-03-28 | Критикал Кэа Дайэгностикс, Инк. | Способы прогнозирования риска развития гипертензии |
RU2015110054A (ru) | 2012-08-21 | 2016-10-10 | Критикал Кэа Дайэгностикс, Инк. | Мультимаркерная стратификация риска |
CN106461636A (zh) * | 2014-01-10 | 2017-02-22 | 重症监护诊断股份有限公司 | 用于测定心力衰竭风险的方法和系统 |
US10324089B2 (en) | 2014-12-11 | 2019-06-18 | Critical Care Diagnostics, Inc. | Test apparatus and methods for ST2 cardiac biomarker |
US10079073B2 (en) | 2014-12-11 | 2018-09-18 | Critical Care Diagnostics, Inc. | Test apparatus and methods for ST2 cardiac biomarker |
US20180252724A1 (en) | 2015-08-28 | 2018-09-06 | Mcmaster University | Method of Determining Risk of an Adverse Cardiac Event |
US20170220749A1 (en) * | 2016-02-01 | 2017-08-03 | MD Aware LLC | Systems and methods for identifying and using medical calculators |
EP3446124A1 (en) * | 2016-04-18 | 2019-02-27 | Roche Diagnostics GmbH | Soluble st2 for the identification of progressors to lvh in the general population |
US12014832B2 (en) * | 2017-06-02 | 2024-06-18 | University Of Florida Research Foundation, Incorporated | Method and apparatus for prediction of complications after surgery |
RU2677611C1 (ru) * | 2018-04-16 | 2019-01-17 | Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) | Способ прогнозирования неблагоприятных сердечно-сосудистых событий в течение 12 месяцев у больных хронической сердечной недостаточностью с рецидивом стенокардии после реваскуляризации миокарда |
US11446009B2 (en) | 2018-12-11 | 2022-09-20 | Eko.Ai Pte. Ltd. | Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images |
US12001939B2 (en) | 2018-12-11 | 2024-06-04 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views |
US11931207B2 (en) | 2018-12-11 | 2024-03-19 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device |
US20220399122A1 (en) * | 2019-11-01 | 2022-12-15 | Nec Corporation | Risk prediction apparatus, risk prediction method, and computer program |
Family Cites Families (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4208479A (en) | 1977-07-14 | 1980-06-17 | Syva Company | Label modified immunoassays |
US5206140A (en) | 1988-06-24 | 1993-04-27 | Research Corporation Technologies, Inc. | Assay for soluble crosslinked fibrin polymers |
JPH0731479Y2 (ja) | 1989-06-02 | 1995-07-19 | 内橋エステック株式会社 | 温度ヒューズ |
US5217899A (en) | 1990-08-24 | 1993-06-08 | The General Hospital Corporation | Cell stretching apparatus |
JP2665850B2 (ja) | 1991-11-14 | 1997-10-22 | 塩野義製薬株式会社 | hBNPのC端を認識するモノクロ−ナル抗体 |
GB9211686D0 (en) | 1992-06-03 | 1992-07-15 | Medisinsk Innovation A S | Chemical compounds |
JP2732005B2 (ja) | 1992-12-14 | 1998-03-25 | 眞一 富永 | ヒトst2をコードするdna、該dnaの発現産物、該dnaを発現させることによる発現産物の製造方法 |
US6066322A (en) | 1995-03-03 | 2000-05-23 | Millennium Pharmaceuticals, Inc. | Methods for the treatment of immune disorders |
WO1998007754A1 (en) | 1996-08-23 | 1998-02-26 | Human Genome Sciences, Inc. | T1 receptor-like ligand ii |
EP0981619A1 (en) | 1997-02-28 | 2000-03-01 | Human Genome Sciences, Inc. | T1/st2-receptor ligand iii |
PT1493439E (pt) | 1997-04-02 | 2012-01-10 | Brigham & Womens Hospital | Meio de avaliação do perfil de risco de um indivíduo para uma doença aterosclerótica |
ATE489633T1 (de) | 1997-06-10 | 2010-12-15 | Lpath Inc | Verfahren zum frühzeitigen nachweis herzerkrankungen |
JP3516655B2 (ja) | 1997-09-11 | 2004-04-05 | 塩野義製薬株式会社 | Bnpの免疫測定法 |
US6309888B1 (en) | 1998-09-04 | 2001-10-30 | Leuven Research & Development Vzw | Detection and determination of the stages of coronary artery disease |
GB9827348D0 (en) | 1998-12-12 | 1999-02-03 | Univ Leicester | Natriuretic peptide |
AU2055300A (en) | 1998-12-18 | 2000-07-03 | Scios Inc. | Methods for detection and use of differentially expressed genes in disease states |
AU5309600A (en) | 1999-06-02 | 2000-12-18 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the treatment and diagnosis of immune disorders |
FR2795823B1 (fr) | 1999-07-01 | 2001-11-23 | Inst Nat Sante Rech Med | Methodes et kits pour le diagnostic ou le suivi d'une pathologie synoviale ou osteoarticulaire comprenant l'utilisation d'un marqueur specifique de la degradation du tissu synovial |
US6323334B1 (en) | 1999-09-24 | 2001-11-27 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules encoding a 103 gene product and uses therefor |
AU2001218871A1 (en) | 2000-03-21 | 2001-10-03 | Takao Arai | Monoclonal antibody and method and kit for the immunoassay of soluble human st2 with the use of the same |
FR2807170B1 (fr) | 2000-03-30 | 2002-06-28 | Sipal | Charniere elastique a frottement reduit |
JP2004506443A (ja) | 2000-08-22 | 2004-03-04 | ブライハム アンド ウィメンズ ホスピタル インコーポレーテッド | 心血管状態の診断および処置 |
WO2002038794A2 (en) | 2000-11-09 | 2002-05-16 | The Brigham And Women's Hospital, Inc. | Cardiovascular disease diagnostic and therapeutic targets |
US6537221B2 (en) | 2000-12-07 | 2003-03-25 | Koninklijke Philips Electronics, N.V. | Strain rate analysis in ultrasonic diagnostic images |
FI20010019A (fi) | 2001-01-05 | 2002-07-06 | Biohit Oyj | Menetelmä atrofisen diagnostisoimiseksi |
US20040253637A1 (en) | 2001-04-13 | 2004-12-16 | Biosite Incorporated | Markers for differential diagnosis and methods of use thereof |
US7713705B2 (en) | 2002-12-24 | 2010-05-11 | Biosite, Inc. | Markers for differential diagnosis and methods of use thereof |
EP1666881B1 (en) | 2001-05-04 | 2010-02-17 | Biosite Incorporated | Diagnostic markers of acute coronary syndromes and methods of use thereof |
US6905827B2 (en) | 2001-06-08 | 2005-06-14 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
WO2003022987A2 (en) | 2001-07-26 | 2003-03-20 | Eos Biotechnology, Inc. | Methods of diagnosis of hepatitis c infection, compositions and methods of screening for modulators of hepatitis c infection |
US6810284B1 (en) | 2001-11-21 | 2004-10-26 | Pacesetter, Inc. | Implantable cardiac stimulation system and method for monitoring diastolic function |
PT3072978T (pt) | 2002-05-09 | 2018-10-15 | Brigham & Womens Hospital Inc | 1l1rl-1 como um marcador de doença cardiovascular |
US8263325B2 (en) | 2002-11-15 | 2012-09-11 | Ottawa Heart Institute Research Corporation | Predicting, detecting and monitoring treatment of cardiomyopathies and myocarditis |
US20070042978A1 (en) | 2002-12-19 | 2007-02-22 | Jean-Philippe Girard | Nf-hev compositions and methods of use |
US20040133079A1 (en) | 2003-01-02 | 2004-07-08 | Mazar Scott Thomas | System and method for predicting patient health within a patient management system |
US20040220155A1 (en) | 2003-03-28 | 2004-11-04 | Pharmacia Corporation | Method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith |
US20060257558A1 (en) | 2003-10-31 | 2006-11-16 | Hiroshi Nomura | Plasma polymerization of atomically modified surfaces |
EP1711622A2 (en) | 2003-11-26 | 2006-10-18 | Applera Corporation | Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof |
WO2005055810A2 (en) | 2003-12-05 | 2005-06-23 | The Cleveland Clinic Foundation | Risk markers for cardiovascular disease |
US20050196817A1 (en) | 2004-01-20 | 2005-09-08 | Molecular Staging Inc. | Biomarkers for sepsis |
NZ549040A (en) | 2004-02-17 | 2009-07-31 | Schering Corp | Use for interleukin-33 (IL33) and the IL-33 receptor complex |
JP2005291899A (ja) | 2004-03-31 | 2005-10-20 | Akira Matsumori | 心疾患の検査法 |
EP1849009B1 (en) | 2005-01-24 | 2008-10-29 | F. Hoffmann-La Roche AG | The use of cardiac hormones for assessing a cardiovascular risk with respect to the administration of anti-inflammatory drugs. |
EP1731910A1 (en) | 2005-06-07 | 2006-12-13 | F. Hoffmann-La Roche Ag | Use of NT-proANP and NT-proBNP for diagnosing cardiac diseases |
US20070021977A1 (en) | 2005-07-19 | 2007-01-25 | Witt Biomedical Corporation | Automated system for capturing and archiving information to verify medical necessity of performing medical procedure |
JP4820192B2 (ja) | 2006-03-17 | 2011-11-24 | 一般財団法人化学及血清療法研究所 | 急性冠症候群でのadamts13の測定と利用 |
ES2646142T3 (es) * | 2006-04-24 | 2017-12-12 | Critical Care Diagnostics, Inc. | Evaluación de la eficacia de un tratamiento en un sujeto en función de los niveles de ST2 |
WO2007143295A2 (en) | 2006-04-27 | 2007-12-13 | Critical Care Diagnostics, Inc. | Interleukin-33 (il-33) for the diagnosis and prognosis of cardiovascular disease |
DK2021796T3 (da) | 2006-05-01 | 2012-05-29 | Critical Care Diagnostics Inc | Diagnose af hjerte-kar-sygdom |
DK2019965T3 (en) | 2006-05-02 | 2015-07-20 | Critical Care Diagnostics Inc | DIFFERENTIAL BETWEEN LUNG AND Cardiovascular Disease |
US8147817B2 (en) | 2006-05-04 | 2012-04-03 | The Brigham And Women's Hospital, Inc. | IL-33 in the treatment and diagnosis of diseases and disorders |
RU2312591C1 (ru) | 2006-06-14 | 2007-12-20 | Государственное образовательное учреждение высшего профессионального образования "Санкт-Петербургская государственная медицинская академия им. И.И. Мечникова Федерального агентства по здравоохранению и социальному развитию" | Способ прогнозирования развития риска внезапной смерти у больных с лево- и правожелудочковой экстрасистолией |
CA2554659A1 (en) * | 2006-07-25 | 2006-11-24 | 1128971 Alberta Ltd. | Hanger flange for hanging a tubular body in a well |
US20080233191A1 (en) * | 2007-03-22 | 2008-09-25 | Brent Blackburn | Use of ranolazine for elevated brain-type natriuretic peptide |
US20090111708A1 (en) * | 2007-05-11 | 2009-04-30 | Seddon Johanna M | Polynucleotides associated with age-related macular degeneration and methods for evaluating patient risk |
US20100267062A1 (en) * | 2007-09-26 | 2010-10-21 | Norbert Frey | Osteopontin as Novel Prognostic Biomarker for Heart Failure |
FR2923029B1 (fr) | 2007-10-26 | 2009-11-20 | Minima | Lunettes de type sans entourage a branches filaires |
WO2009075566A1 (en) * | 2007-12-12 | 2009-06-18 | Erasmus University Medical Center Rotterdam | Biomarkers for cardiovascular disease |
SI2827152T1 (sl) * | 2008-04-18 | 2016-10-28 | Critical Care Diagnostics,Inc. | Napovedovanje tveganja večjih neželenih srčno-žilnih dogodkov |
WO2010054810A1 (en) * | 2008-11-11 | 2010-05-20 | B.R.A.H.M.S Ag | Prognosis and risk assessment in patients suffering from heart failure by determining the level of adm and bnp |
WO2011000874A1 (en) * | 2009-07-01 | 2011-01-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting cardiovascular mortality risk |
BR112012011230A2 (pt) * | 2009-11-13 | 2016-04-05 | Bg Medicine Inc | fatores de risco e previsão de infarto do miocárdio |
US8258456B2 (en) * | 2009-11-27 | 2012-09-04 | Himax Imaging, Inc. | Image sensor |
RU2625014C2 (ru) * | 2010-04-09 | 2017-07-11 | Критикал Кэа Дайэгностикс, Инк. | Антитела против растворимого st-2 человека и способы анализа |
RU2618437C2 (ru) * | 2010-11-01 | 2017-05-03 | Б.Р.А.Х.М.С Гмбх | Оценка прогноза и риска пациентов с неспецифическими жалобами |
RU2452394C1 (ru) | 2010-11-09 | 2012-06-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Ульяновский государственный университет | Способ прогнозирования риска смерти больных хронической сердечной недостаточностью |
US8728742B2 (en) | 2011-03-17 | 2014-05-20 | Critical Care Diagnostics, Inc. | Methods predicting risk of an adverse clinical outcome |
JP6134316B2 (ja) | 2011-07-18 | 2017-05-24 | クリティカル ケア ダイアグノスティクス インコーポレイテッド | 心臓血管疾患を治療する方法および運動療法の有効性を予測する方法 |
EP3434260A1 (en) | 2012-05-18 | 2019-01-30 | Critical Care Diagnostics, Inc. | Methods for treating or predicting risk of ventricular tachyarrhythmia event |
RU2019107598A (ru) | 2012-08-16 | 2019-03-28 | Критикал Кэа Дайэгностикс, Инк. | Способы прогнозирования риска развития гипертензии |
RU2015110054A (ru) | 2012-08-21 | 2016-10-10 | Критикал Кэа Дайэгностикс, Инк. | Мультимаркерная стратификация риска |
JP6178687B2 (ja) | 2013-09-27 | 2017-08-09 | 富士機械工業株式会社 | グラビア塗工装置 |
CN106461636A (zh) | 2014-01-10 | 2017-02-22 | 重症监护诊断股份有限公司 | 用于测定心力衰竭风险的方法和系统 |
USD770057S1 (en) | 2014-04-14 | 2016-10-25 | Critical Care Diagnostics, Inc. | Blood test kit |
US9934249B2 (en) | 2014-06-03 | 2018-04-03 | Conduent Business Machines Services, Llc | Systems and methods for context-aware and personalized access to visualizations of road events |
USD800333S1 (en) | 2014-09-23 | 2017-10-17 | Critical Care Diagnostics, Inc. | Blood test kit |
USD800332S1 (en) | 2014-09-23 | 2017-10-17 | Critical Care Diagnostics, Inc. | Blood test kit |
US10324089B2 (en) | 2014-12-11 | 2019-06-18 | Critical Care Diagnostics, Inc. | Test apparatus and methods for ST2 cardiac biomarker |
US10079073B2 (en) | 2014-12-11 | 2018-09-18 | Critical Care Diagnostics, Inc. | Test apparatus and methods for ST2 cardiac biomarker |
-
2013
- 2013-08-21 RU RU2015110054A patent/RU2015110054A/ru not_active Application Discontinuation
- 2013-08-21 CN CN201380054795.8A patent/CN104737170A/zh active Pending
- 2013-08-21 CN CN202010424423.1A patent/CN111834009A/zh active Pending
- 2013-08-21 IN IN1767DEN2015 patent/IN2015DN01767A/en unknown
- 2013-08-21 CA CA2882303A patent/CA2882303A1/en not_active Abandoned
- 2013-08-21 SG SG11201501271TA patent/SG11201501271TA/en unknown
- 2013-08-21 WO PCT/US2013/056020 patent/WO2014031764A1/en active Application Filing
- 2013-08-21 MX MX2015002254A patent/MX2015002254A/es active IP Right Grant
- 2013-08-21 EP EP13831501.5A patent/EP2888687B1/en active Active
- 2013-08-21 JP JP2015528625A patent/JP6450679B2/ja active Active
- 2013-08-21 US US13/972,596 patent/US20140058743A1/en not_active Abandoned
- 2013-08-21 SG SG10201608854TA patent/SG10201608854TA/en unknown
- 2013-08-21 AU AU2013305829A patent/AU2013305829A1/en not_active Abandoned
-
2015
- 2015-02-20 MX MX2020009943A patent/MX2020009943A/es unknown
- 2015-09-08 HK HK15108723.0A patent/HK1208092A1/xx unknown
- 2015-12-23 HK HK15112621.5A patent/HK1212057A1/xx unknown
-
2016
- 2016-12-20 US US15/385,095 patent/US10303844B2/en active Active
-
2018
- 2018-12-10 JP JP2018230514A patent/JP6621520B2/ja not_active Expired - Fee Related
-
2019
- 2019-03-13 AU AU2019201709A patent/AU2019201709B2/en not_active Ceased
- 2019-04-10 US US16/380,513 patent/US10741290B2/en active Active
- 2019-11-19 JP JP2019208375A patent/JP6902083B2/ja active Active
-
2020
- 2020-07-07 US US16/922,580 patent/US20200335220A1/en not_active Abandoned
-
2021
- 2021-04-06 AU AU2021202116A patent/AU2021202116A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MX2020009943A (es) | 2020-10-16 |
SG10201608854TA (en) | 2016-12-29 |
JP6450679B2 (ja) | 2019-01-09 |
CN104737170A (zh) | 2015-06-24 |
EP2888687A1 (en) | 2015-07-01 |
MX2015002254A (es) | 2015-05-08 |
US20200335220A1 (en) | 2020-10-22 |
AU2021202116A1 (en) | 2021-05-06 |
AU2019201709A1 (en) | 2019-04-04 |
JP6621520B2 (ja) | 2019-12-18 |
HK1212057A1 (en) | 2016-06-03 |
AU2013305829A1 (en) | 2015-03-05 |
JP6902083B2 (ja) | 2021-07-14 |
HK1208092A1 (en) | 2016-02-19 |
US20190237197A1 (en) | 2019-08-01 |
US20140058743A1 (en) | 2014-02-27 |
US10741290B2 (en) | 2020-08-11 |
US10303844B2 (en) | 2019-05-28 |
EP2888687A4 (en) | 2016-04-13 |
JP2020034573A (ja) | 2020-03-05 |
JP2019053086A (ja) | 2019-04-04 |
EP2888687B1 (en) | 2023-08-02 |
AU2019201709B2 (en) | 2021-01-07 |
SG11201501271TA (en) | 2015-03-30 |
RU2015110054A (ru) | 2016-10-10 |
JP2015532715A (ja) | 2015-11-12 |
CA2882303A1 (en) | 2014-02-27 |
US20170169179A1 (en) | 2017-06-15 |
CN111834009A (zh) | 2020-10-27 |
WO2014031764A1 (en) | 2014-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2015DN01767A (sl) | ||
WO2009129454A3 (en) | Predicting risk of major adverse cardiac events | |
EA201590027A1 (ru) | Способы детекции заболеваний или состояний | |
EA201590994A1 (ru) | Способ увеличения гидродинамического объема полипептида путем присоединения карбоксиконцевого пептида гонадотропина | |
EA201690213A1 (ru) | Композиции и способ лечения связанных с комплементом состояний | |
PH12014502436A1 (en) | In vitro method for the diagnosis and surveillance of cancer | |
DK2704644T3 (da) | Kanyle til et donororgan med eller uden en atorisk manchet eller lap | |
MX360479B (es) | Anticuerpos contra microbioma, factores de estres y marcadores de mastocitos como marcadores de diagnostico para ibs. | |
WO2013167727A3 (en) | Method for determining arthritis relapse risk | |
FI20115367A0 (fi) | Menetelmä sydän- ja verisuonitapahtumien määrittämiseksi käyttämällä IGFBP-fragmentteja | |
GB201114909D0 (en) | Biomarkers for lysosomal storage disorders | |
WO2012122094A3 (en) | Biomarkers of cardiac ischemia | |
BR112013017683A2 (pt) | método de medir a concentração de um analito em uma solução aquosa | |
NZ720311A (en) | Identification of a new polypeptide hormone for maintenance of optimal body weight and blood glucose | |
WO2013106851A3 (en) | Syncollin, pancreatic triacylglycerol lipase, and other biomarkers for diabetes | |
UA81994U (ru) | Способ прогнозирования развития нестабильной стенокардии у больных с сахарным диабетом 2 типа | |
UA81148U (ru) | Способ прогнозирования последствий ишемического инсульта | |
UA82989U (uk) | Спосіб прогнозування ризику розвитку артеріальної гіпертензії у хворих на акромегалію | |
UA89609U (ru) | Способ прогнозирования развития остеопороза при системной красной волчанке | |
UA72314U (ru) | Способ ранней диагностики гемодинамических нарушений у больных циррозом печени невирусного происхождения | |
UA89610U (ru) | Способ прогнозирования развития остеопороза при системной красной волчанке | |
UA81143U (ru) | Способ прогнозирования риска развития острого нарушения мозгового кровообращения | |
UA103559U (ru) | Способ прогнозирования развития недостаточности цинка у пациентов отделений интенсивной терапии | |
UA95623U (uk) | Спосіб прогнозування зрощення перелому | |
UA83495U (ru) | Способ диагностики нарушений плацентарного комплекса |